Article
The Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology Advancements
1 Jan 2016
Abstract excerpt
Prostate cancer (PC) is the second most common form of cancer in men worldwide. Biomarkers have emerged as essential tools for treatment and assessment since the variability of disease behavior, the cost and diversity of treatments, and the related impairment of quality of life have given rise to a need for a personalized approach. High-throughput technology platforms in proteomics and genomics have accelerated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
